Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival

Abstract

// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Luc G.T. Morris1,2,*, Nadeem Riaz1,3*, Alexis Desrichard1, Yasin Şenbabaoğlu4, A. Ari Hakimi2, Vladimir Makarov1, Jorge S. Reis-Filho1,5 and Timothy A. Chan1,3 1 Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 2 Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA 3 Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA 4 Computational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA 5 Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA * These authors have contributed equally to this work Correspondence to: Luc G.T. Morris, email: // <![CDATA[ mail("morrisl","mskcc",1,"") // ]]> Timothy A. Chan, email: // <![CDATA[ mail("chant","mskcc",1,"") // ]]> Keywords: heterogeneity, evolution, survival, cancer, immune surveillance Received: January 14, 2016 Accepted: January 21, 2016 Published: January 28, 2016